The Onsemble Community Forum is your central hub to connect, collaborate, and grow alongside a network of clinical research professionals who rely on Advarra's suite of technology solutions. Built for research teams across academic medical centers, cancer centers, health systems, and other leading institutions, the forum provides a collaborative environment where users and Advarra experts engage in meaningful, product-focused discussions. Whether you're troubleshooting, sharing insights, or exploring best practices, the forum is designed to foster knowledge exchange and strengthen research operations. Within the forum, you’ll have access to product documentation and updates, on-demand webinars, detailed release notes, as well as information about upcoming events, collaboration calls, and live sessions. By joining the community, you can stay informed, share your expertise, and collaborate with peers who are advancing clinical research every day.
Review and adjust the content you currently follow to stay aligned with what matters most to you.
The post Emerging Use of Bacteriophages, Natural Predators of Bacteria, to Combat Antibiotic Resistance in the Clinic and Beyond: A Review of the Field and Biosafety Assessment appeared first on Advarra.
Daniel Eisenman, James Riddle, and Stephanie Pyle from Advarra all co-authored the published article, “Guidelines needed for the use of The post Guidelines needed for the use of AI in the preparation or review of IRB, IBC,and IACUC applications appeared first on Advarra.
Beyond the Breakthrough explores the challenges of CAR-T oncology trials, from complex logistics and safety risks to the critical role of cross-disciplinary coordination in delivering personalized cancer therapies. The post Beyond the Breakthrough: Navigating the realities of CAR-T cell oncology trials appeared first on Advarra.
Advarra has launched the Council for Responsible AI in Clinical Trials to ensure the ethical use of AI in clinical The post Navigating AI in Clinical Trials: Insights from Advarra’s Laura Russell appeared first on Advarra.
You can’t throw a rock in clinical research right now without hitting someone pitching some new AI-enabled app, solution, process The post Clinical Trials Get A Council For AI Oversight appeared first on Advarra.
Ophthalmology is quietly becoming gene therapy’s next big frontier. Here’s how the science, the patients, and the regulations are aligning. The post Gene Therapy Successes in Ophthalmology appeared first on Advarra.
Stuart Cotter dives in how today’s single sign-on reduces site burden and spearheads clinical system interoperability. The post The Latest Advancements in Single Sign-On Technology appeared first on Advarra.
Advarra’s Elisa Cascade joins other industry leaders, SCRS’ Jimmy Bechtel, Advarra’s Elisa Cascade, Tufts Center for the Study of Drug The post The “One-and-Done” PI & Measuring the Current Site Landscape appeared first on Advarra.
Christine Senn digs into the results of Advarra’s Site-Sponsor-CRO Collaboration survey to reveal some new trends to expect in the The post Clinical Research Trends to Expect in 2025: More Complex, Less Connected appeared first on Advarra.
Advarra deep-dives into special considerations needed for high-quality and sensitive pediatric oncology trial IRB reviews. The post A balancing act: Innovating IRBs for the future of pediatric oncology research appeared first on Advarra.
Kyle Naylor didn’t set out to work in the IRB world—but once he found it, he never looked back. Now a team lead supporting […] The post Q&A with Advarra’s Client Services Team Lead Kyle Naylor appeared first on Advarra.
How operational insight, performance data, and patient access signals can strengthen clinical trial site decisions Choosing the right sites can […] The post A Practical Checklist for Building Confidence in Site Selection appeared first on Advarra.
IRB approval is a critical milestone in clinical research, but it isn’t the end of the oversight process. For sponsors, approval marks […] The post Sponsor’s Guide to IRB Approval (Part VI): After IRB Approval: Compliance, Multi-Site Oversight, and Turning Review into a Strategic Advantage appeared first on Advarra.
MaryJo Carter has spent more than nine years at Advarra, growing alongside the organization and helping shape how teams show up for […] The post Q&A with Advarra’s Manager of Ongoing Review MaryJo Carter appeared first on Advarra.
Institutional review board (IRB) approval is a critical milestone in clinical research, but it can also become a source of […] The post Sponsor’s Guide to IRB Approval (Part V): How to Speed Up IRB Approvals appeared first on Advarra.
Balancing innovation, statistical rigor, and independent oversight in increasingly complex clinical trials Clinical trials are no longer static. Over the […] The post Data Safety Monitoring Boards (DSMBs) in the Era of AI and Adaptive Clinical Trials appeared first on Advarra.
Multisite research and clinical trials increasingly rely on a single IRB (sIRB) for review. This increase reflects federal mandates, sponsor expectations, and the operational realities of modern multisite or cooperative research. For institutions with a local […] The post Why Should Local IRBs and HRPPs Collaborate with External IRBs? appeared first on Advarra.
A strong protocol and well-drafted consent form are essential, but they are not enough on their own to support a […] The post Sponsor’s Guide to IRB Approval (Part IV): Preparing IRB Documents That Prevent Delays appeared first on Advarra.
Evan Sander knows firsthand that clinical research is never just about processes or paperwork—it’s about people. As associate director of […] The post Q&A with Advarra’s Associate Director of Client Success Evan Sander appeared first on Advarra.
Let me start with a question I get more and more frequently from research sites as mRNA continues to expand […] The post Does mRNA Require IBC Review? How the NIH Guidelines Apply to Clinical Trials appeared first on Advarra.
It looks like you're new here. Sign in or register to get started.